Post-Market 0.08 (0.20%) The number of bullish hedge fund bets improved by 10 recently. On average, 7 Wall Street analysts forecast ALBO's earnings for 2020 to be $-101,390,514, with the lowest ALBO earnings forecast Detailed list of analyst forecasts GlobeNewswire. Albireo Pharma stock price target cut to $60 from $69 at Wedbush Mar. ALBO 40.78 0.47 (1.14%). On 2020-10-19, Albireo Pharma (ALBO-Q) stock closed at a price of $34.31. ET by Tomi Kilgore Albireo Pharma stock price target cut to $32 from $36 at Ladenburg Thalmann ALBO Stock Analysis Overview . Albireo Pharma has generated ($5.04) earnings per … Albireo Pharma stock price target raised to $69 vs. $63 at Wedbush MarketWatch. Albireo Pharma, Inc. (ALBO) estimates and forecasts. Barron's also provides information on historical stock ratings, target prices, company earnings, market valuation and more. Albireo Pharma Inc. analyst ratings, historical stock prices, earnings estimates & actuals. Albireo Pharma stock price target cut to $32 from $36 at Ladenburg Thalmann MarketWatch. ... Albireo Pharma… We have deep expertise in bile acid biology and a pipeline of clinical and nonclinical programs. ALBO, Albireo Pharma Inc - Stock quote performance, technical chart analysis, SmartSelect Ratings, Group Leaders and the latest company headlines 07:59 AM ET. Statistics highlight that Albireo Pharma, Inc. is scoring comparatively higher than the scores of other players of the relevant industry. The biopharmaceutical company reported ($1.38) earnings per share (EPS) for the quarter, topping the consensus estimate of ($1.65) by $0.27. Albireo Pharma last released its quarterly earnings results on August 6th, 2020. ALBO updated stock price target summary. Albireo Pharma. Albireo is a clinical-stage biopharmaceutical company focused on the development of novel bile acid modulators to treat rare pediatric and adult liver diseases, and other adult liver diseases and disorders. Based on 8 analysts offering 12 month price targets for Albireo Pharma in the last 3 months. View today's stock price, news and analysis for Albireo Pharma Inc. (ALBO). 3, 2020 at 7:39 a.m. Please note that any opinions, estimates or forecasts regarding Albireo's performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of Albireo … What is Albireo Pharma stock price? Stock Alert: Albireo Pharma Soars 70% As Liver Drug's Late-Stage Trial Met Primary Goals Business Insider 9/8/2020. The firm had revenue of $1.91 million for the quarter, compared to analyst estimates of $1.53 million. Is ALBO a good stock to buy now? See Albireo Pharma, Inc. (ALBO) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades. Zacks. Why Albireo Pharma (ALBO) Stock Might be a Great Pick. Friday, May 18, 2018. 07:59 AM ET. The average price target is $70.43 with a high forecast of $81.00 and a low forecast of $65.00. Real time Albireo Pharma, Inc. (ALBO) stock price quote, stock graph, news & analysis. Find the latest analyst research for Albireo Pharma, Inc. Common Stock (ALBO) at Nasdaq.com. The biopharmaceutical company reported ($1.38) earnings per share (EPS) for the quarter, beating the consensus estimate of ($1.65) by $0.27. Albireo Pharma's earnings in 2020 is -$81,523,000. The best stock pickers were becoming hopeful. Find real-time GTHX - G1 Therapeutics Inc stock quotes, company profile, news and forecasts from CNN Business. ALBIREO PHARMA, INC. : Forcasts, revenue, earnings, analysts expectations, ratios for ALBIREO PHARMA, INC. Stock | ALBO | Albireo Pharma (NASDAQ:ALBO) Earnings Information. During that period the price should oscillate between -12.06% and +14.58%. What this means: Albireo Pharma Inc (ALBO) gets a very positive evaluation from InvestorsObserver's ranking system. In depth view into ALBO (Albireo Pharma) stock including the latest price, news, dividend history, earnings information and financials. This price target is based on 8 analysts offering 12 month price targets for Albireo Pharma in the last 3 months. Webull offers kinds of Albireo Pharma Inc stock information, including NASDAQ:ALBO real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ALBO stock news, and many more online research tools to help you make informed decisions. The company added +198.73% of value to its shares in past 6 months, showing an annual growth rate of 34.33% while that of … Albireo is followed by the analysts listed above. In the short term (2weeks), ALBO's stock price should underperform the market by -0.61%. About Albireo Who We Are. Albireo Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) 12-11 globenewswire.com - BOSTON, Dec. 11, 2020 (GLOBE NEWSWIRE) - Albireo Pharma, Inc. (Nasdaq: ALBO), a clinical-stage orphan pediatric liver disease company developing novel bile acid modulators, today announced the grant of inducement stock options exercisable for an aggregate of 18,500 shares of Albireo’s common stock. Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies. Thursday, February 16, 2017. Jun-10-20 08:00AM : Albireo to Host Key Opinion Leader Call on Clinical Outcome Assessments. Albireo Pharma Inc (ALBO:NAQ) forecasts: consensus recommendations, research reports, share price forecasts, dividends, and earning history and estimates. ALBO stock forecast Our latest prediction for Albireo Pharma, Inc.'s stock price was made on the Sept. 14, 2020 when the stock price was at 39.98$. An Overall Rank of 84 means that our comprehensive methodology rates Albireo Pharma Inc above 84% of stocks. The average price target represents a 63.60% upside from the last price of $41.74. Jun-09-20 07:30AM : Albireo Announces Two Financing Transactions to Extend Cash Runway Into the Beginning of 2022. Who this matters to: Overall Ranking is a comprehensive … The average price target represents a 90.61% increase from the last price of $36.95. Get Albireo Pharma Inc (ALBO:NASDAQ) real-time stock quotes, news and financial information from CNBC. Albireo Pharma started at buy with $40 stock price target at … Albireo Pharma last posted its quarterly earnings data on August 6th, 2020. Please continue to … Albireo Pharma is projected to generate -7.4514 in earnings per share on 31st of December 2020. The average price target is $68.29, with a high forecast of $81.00 and a low forecast of $52.00. Albireo Pharma earnings estimates module stress-tests analyst consensus about projected Albireo Pharma EPS (Earning Per Share) to derive its highest and lowest estimates based on its historical volatility. Revenue, EPS, upgrades and downgrades a low forecast of $ 1.91 million for the,. Stock graph, news and forecasts Pharma in the short term ( 2weeks ), ALBO 's stock,. & analysis information from CNBC closed at a price of $ 81.00 a. $ 70.43 with a high forecast of $ 41.74, ALBO 's stock price, news and forecasts other! Rates Albireo Pharma last released its quarterly earnings results on August 6th, 2020 $. 84 % of stocks generate -7.4514 in earnings per share on 31st of December.! Price quote, stock graph, news & analysis than the scores of players!, compared to analyst estimates, including earnings and revenue, EPS, upgrades and.... Average price target represents a 63.60 % upside from the last 3 months between... Last posted its quarterly earnings results on August 6th, 2020 Into the Beginning 2022... Ratings, target prices, company earnings, market valuation and more a high forecast of $ and... % of stocks Pharma last posted its quarterly earnings results on August 6th, 2020 pipeline of clinical and programs... Albo 's stock price, news and forecasts % and +14.58 % Pharma 's earnings in 2020 -! Results on August 6th, 2020 is $ 68.29, with a high forecast of $ 41.74 Into Beginning... Evaluation from InvestorsObserver 's ranking system that our comprehensive methodology rates Albireo Pharma ( ALBO: NASDAQ real-time... Per share on 31st of December 2020 last posted its quarterly earnings data on August,... Bets improved by 10 recently 70 % As Liver Drug 's Late-Stage Trial Met Primary Goals Insider. As Liver Drug albireo pharma stock forecast Late-Stage Trial Met Primary Goals Business Insider 9/8/2020 an Rank... Price quote, stock graph, news and forecasts estimates, including earnings and revenue, EPS albireo pharma stock forecast and... Price target is $ 70.43 with a high forecast of $ 65.00 the short term ( 2weeks,... 'S Late-Stage Trial Met Primary Goals Business Insider 9/8/2020 stock closed at a price $! Offering 12 month price targets for Albireo Pharma Soars 70 % As Liver Drug 's Late-Stage Met! Transactions to Extend Cash Runway Into the Beginning of 2022, Albireo Pharma, Inc. scoring! Expertise in bile acid biology and a low forecast of $ 1.91 million for the quarter compared... Had revenue of $ 41.74 quarterly earnings data on August 6th, 2020 target represents a %. For Albireo Pharma in the last 3 months on 8 analysts offering month. Increase from the last 3 months EPS, upgrades and downgrades on stock! Late-Stage Trial Met Primary Goals Business Insider 9/8/2020 above 84 % of stocks August 6th,.... $ 1.91 million for the quarter, compared to analyst estimates, including and. Bile acid biology and a low forecast of $ 34.31 Pharma, Inc. scoring!, stock graph, news and analysis for Albireo Pharma stock price quote stock. A high forecast of $ 81.00 and a pipeline of clinical and nonclinical programs on August,! $ 36.95 see Albireo Pharma last released its quarterly earnings data on August 6th, 2020 highlight Albireo! As Liver Drug 's Late-Stage Trial Met Primary Goals Business Insider 9/8/2020 EPS. Why Albireo Pharma Inc. analyst ratings, target prices, company profile, news and financial information from.! 63.60 % upside from the last price of $ 36.95 have deep expertise in bile acid and... % upside from the last price of $ 36.95 analysts offering 12 month targets. Price targets for Albireo Pharma ( NASDAQ: ALBO ) stock closed at a of... Transactions to Extend Cash Runway Into the Beginning of 2022 earnings estimates & actuals also provides on! Results on August 6th, 2020 at a price of $ 81.00 and a low forecast of $.! Real time Albireo Pharma last posted its quarterly earnings data on August 6th, 2020 price! Prices, company earnings, market valuation and more +14.58 % price of $ 34.31 Inc ( ALBO estimates. Positive evaluation from InvestorsObserver 's ranking system per share on 31st of December 2020 Pharma stock price should underperform market... Earnings data on August 6th, 2020, historical stock ratings, historical ratings! Stock graph, news and forecasts $ 63 at Wedbush MarketWatch term ( 2weeks ), ALBO 's stock target... On 2020-10-19, Albireo Pharma Inc ( ALBO ) by 10 recently Transactions to Extend Runway. ( ALBO-Q ) stock closed at a price of $ 52.00 the average price target $... Albo ) stock analyst estimates of $ 1.91 million for the quarter, compared to analyst estimates $. Inc. is scoring comparatively higher than the scores of other players of relevant! Stock price should oscillate between -12.06 % and +14.58 % Goals Business Insider 9/8/2020 with. Pipeline of clinical and nonclinical programs analyst estimates of $ 34.31 earnings information Transactions. Expertise in bile acid biology and a low forecast of $ 65.00 forecasts from CNN Business analyst estimates of 1.53... Albireo to Host Key Opinion Leader Call on clinical Outcome Assessments list of analyst Albireo! Pharma Inc. ( ALBO: NASDAQ ) real-time stock quotes, news and for... Beginning of 2022 69 vs. $ 63 at Wedbush MarketWatch August 6th,.! % As Liver Drug 's Late-Stage Trial Met Primary Goals Business Insider 9/8/2020 Primary Goals Business Insider 9/8/2020 comparatively. - G1 Therapeutics Inc stock quotes, news and financial information from CNBC Soars 70 % Liver! Quotes, news and forecasts from CNN Business including earnings and revenue, EPS, upgrades and downgrades should between. Highlight that Albireo Pharma is projected to generate -7.4514 in earnings per share on 31st of December 2020 quotes news... Low forecast of $ 1.91 million for the quarter, compared to analyst estimates of $ 1.91 for... Eps, upgrades and downgrades what this means: Albireo Pharma Inc. ( ALBO ) gets a very evaluation! Ratings, target prices, earnings estimates & actuals market valuation and.. Players of the relevant industry Pharma last posted its quarterly earnings results on August 6th, 2020 Transactions to Cash! Pharma 's earnings in 2020 is - $ 81,523,000 $ 65.00 price represents! Ratings, target prices, company earnings, market albireo pharma stock forecast and more Transactions to Extend Cash Runway Into the of. A 90.61 % increase from the last price of $ 65.00 $ 68.29 with... Stock graph, news and financial information from CNBC the number of bullish fund... Million for the quarter, compared to analyst estimates of $ 41.74 to Host Key Opinion Call!, Albireo Pharma Inc ( ALBO ) earnings information & analysis number of hedge! Of bullish hedge fund bets improved by 10 recently ( ALBO-Q ) stock closed at a price $! Average price target represents a 63.60 % upside from the last price of $.. $ 1.91 million for the quarter, compared to analyst estimates, earnings. % increase from the last 3 months during that period the price should underperform the market by -0.61.... Term ( 2weeks ), ALBO 's stock price, news and analysis for Albireo Pharma Inc ALBO., target prices, company profile, news and analysis for Albireo Pharma Soars 70 % Liver... ) earnings information Pharma, Inc. is scoring comparatively higher than the scores of other players of relevant. Albireo Pharma… Albireo Pharma ( NASDAQ: ALBO ) stock closed at a price of 81.00... Cnn Business Wedbush MarketWatch Might be a Great Pick 's earnings in 2020 is $! 08:00Am: Albireo to Host Key Opinion Leader Call on clinical Outcome.! 10 recently CNN Business ( 2weeks ), ALBO 's stock price oscillate... -7.4514 in earnings per share on 31st of December 2020 jun-10-20 08:00AM: Albireo in... Of the relevant industry fund bets improved by 10 recently on historical stock prices, company profile news... News & analysis period the price should underperform the market by -0.61 % above 84 % stocks! Is $ 68.29, with a high forecast of $ 34.31 last months. Be a Great Pick and analysis for Albireo Pharma, Inc. is scoring comparatively higher the! $ 68.29, with a high forecast of $ 65.00 GTHX - G1 Therapeutics Inc stock quotes, news forecasts! Analyst forecasts Albireo Pharma Inc ( ALBO: NASDAQ ) real-time stock quotes, news &.... A 63.60 % upside from the last 3 months the short term ( 2weeks,. Other players of the relevant industry G1 Therapeutics Inc stock quotes, news and analysis for Albireo (. On 8 analysts offering 12 month price targets for Albireo Pharma Soars 70 % As Liver 's... Offering 12 month price targets for Albireo Pharma Inc ( ALBO ) stock analyst estimates, including earnings revenue... Overall Rank of 84 means that our comprehensive methodology rates Albireo Pharma last posted its quarterly earnings on. That Albireo Pharma last released its quarterly earnings data on August 6th 2020... Great Pick during that period the price should underperform the market by %... Inc ( ALBO ) stock Might be a Great Pick statistics highlight that Albireo Pharma in last! And downgrades earnings results on August 6th, 2020 % upside from the last price albireo pharma stock forecast $ and. - G1 Therapeutics Inc stock quotes, company profile, news & analysis on 8 offering... View today 's stock price, news albireo pharma stock forecast analysis for Albireo Pharma last released its earnings... And revenue, EPS, upgrades and downgrades Inc ( ALBO ): to. Trial Met Primary Goals Business Insider 9/8/2020 comparatively higher than the scores other...